These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 17827009)

  • 1. Synthesis and structure-activity relationship of 4-(2-aryl-cyclopropylamino)-quinoline-3-carbonitriles as EGFR tyrosine kinase inhibitors.
    Pannala M; Kher S; Wilson N; Gaudette J; Sircar I; Zhang SH; Bakhirev A; Yang G; Yuen P; Gorcsan F; Sakurai N; Barbosa M; Cheng JF
    Bioorg Med Chem Lett; 2007 Nov; 17(21):5978-82. PubMed ID: 17827009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization of 6,7-disubstituted-4-(arylamino)quinoline-3-carbonitriles as orally active, irreversible inhibitors of human epidermal growth factor receptor-2 kinase activity.
    Tsou HR; Overbeek-Klumpers EG; Hallett WA; Reich MF; Floyd MB; Johnson BD; Michalak RS; Nilakantan R; Discafani C; Golas J; Rabindran SK; Shen R; Shi X; Wang YF; Upeslacis J; Wissner A
    J Med Chem; 2005 Feb; 48(4):1107-31. PubMed ID: 15715478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 4-Anilino-7,8-dialkoxybenzo[g]quinoline-3-carbonitriles as potent Src kinase inhibitors.
    Berger DM; Dutia M; Birnberg G; Powell D; Boschelli DH; Wang YD; Ravi M; Yaczko D; Golas J; Lucas J; Boschelli F
    J Med Chem; 2005 Sep; 48(19):5909-20. PubMed ID: 16161995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and antiproliferative activity of tyrphostins containing quinoline moieties.
    Brunton VG; Lear MJ; McKeown P; Robins DJ; Workman P
    Anticancer Drug Des; 1996 Sep; 11(6):463-83. PubMed ID: 8836111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, and biological evaluation of substituted 2,3-dihydro-1H-cyclopenta[b]quinolin-9-ylamine related compounds as fructose-1,6-bisphosphatase inhibitors.
    Rosini M; Mancini F; Tarozzi A; Colizzi F; Andrisano V; Bolognesi ML; Hrelia P; Melchiorre C
    Bioorg Med Chem; 2006 Dec; 14(23):7846-53. PubMed ID: 16908175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Tpl2 kinase and TNFalpha production with quinoline-3-carbonitriles for the treatment of rheumatoid arthritis.
    Hu Y; Green N; Gavrin LK; Janz K; Kaila N; Li HQ; Thomason JR; Cuozzo JW; Hall JP; Hsu S; Nickerson-Nutter C; Telliez JB; Lin LL; Tam S
    Bioorg Med Chem Lett; 2006 Dec; 16(23):6067-72. PubMed ID: 16973359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding modes of 6,7 di-substituted 4-anilinoquinoline-3-carbonitriles to EGFR.
    Akula N; Bhalla J; Sridhar J; Pattabiraman N
    Bioorg Med Chem Lett; 2004 Jul; 14(13):3397-400. PubMed ID: 15177440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and antiproliferative activity of unsaturated quinoline derivatives.
    Montgomery GJ; McKeown P; McGown AT; Robins DJ
    Anticancer Drug Des; 2000 Jun; 15(3):171-81. PubMed ID: 11049085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specificity of alpha-cyano-beta-hydroxy-beta-methyl-n-[4-(trifluoromethoxy)phe nyl]-propenamide as an inhibitor of the epidermal growth factor receptor tyrosine kinase.
    Ghosh S; Zheng Y; Jun X; Mahajan S; Mao C; Sudbeck EA; Uckun FM
    Clin Cancer Res; 1999 Dec; 5(12):4264-72. PubMed ID: 10632369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and structure-activity relationships of 6,7-disubstituted 4-anilinoquinoline-3-carbonitriles. The design of an orally active, irreversible inhibitor of the tyrosine kinase activity of the epidermal growth factor receptor (EGFR) and the human epidermal growth factor receptor-2 (HER-2).
    Wissner A; Overbeek E; Reich MF; Floyd MB; Johnson BD; Mamuya N; Rosfjord EC; Discafani C; Davis R; Shi X; Rabindran SK; Gruber BC; Ye F; Hallett WA; Nilakantan R; Shen R; Wang YF; Greenberger LM; Tsou HR
    J Med Chem; 2003 Jan; 46(1):49-63. PubMed ID: 12502359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Syntheses and EGFR kinase inhibitory activity of 6-substituted-4-anilino [1,7] and [1,8] naphthyridine-3-carbonitriles.
    Wissner A; Hamann PR; Nilakantan R; Greenberger LM; Ye F; Rapuano TA; Loganzo F
    Bioorg Med Chem Lett; 2004 Mar; 14(6):1411-6. PubMed ID: 15006373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 4-Anilino-6,7-dialkoxyquinoline-3-carbonitrile inhibitors of epidermal growth factor receptor kinase and their bioisosteric relationship to the 4-anilino-6,7-dialkoxyquinazoline inhibitors.
    Wissner A; Berger DM; Boschelli DH; Floyd MB; Greenberger LM; Gruber BC; Johnson BD; Mamuya N; Nilakantan R; Reich MF; Shen R; Tsou HR; Upeslacis E; Wang YF; Wu B; Ye F; Zhang N
    J Med Chem; 2000 Aug; 43(17):3244-56. PubMed ID: 10966743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a novel class of selective Tpl2 kinase inhibitors: 4-Alkylamino-[1,7]naphthyridine-3-carbonitriles.
    Kaila N; Green N; Li HQ; Hu Y; Janz K; Gavrin LK; Thomason J; Tam S; Powell D; Cuozzo J; Hall JP; Telliez JB; Hsu S; Nickerson-Nutter C; Wang Q; Lin LL
    Bioorg Med Chem; 2007 Oct; 15(19):6425-42. PubMed ID: 17664070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salicylanilides as inhibitors of the protein tyrosine kinase epidermal growth factor receptor.
    Liechti C; Séquin U; Bold G; Furet P; Meyer T; Traxler P
    Eur J Med Chem; 2004 Jan; 39(1):11-26. PubMed ID: 14987830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and structure-activity relationship of 4-substituted 2-(2-acetyloxyethyl)-8-(morpholine-4-sulfonyl)pyrrolo[3,4-c]quinoline-1,3-diones as potent caspase-3 inhibitors.
    Kravchenko DV; Kuzovkova YA; Kysil VM; Tkachenko SE; Maliarchouk S; Okun IM; Balakin KV; Ivachtchenko AV
    J Med Chem; 2005 Jun; 48(11):3680-3. PubMed ID: 15916416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor-guided alignment-based comparative 3D-QSAR studies of benzylidene malonitrile tyrphostins as EGFR and HER-2 kinase inhibitors.
    Kamath S; Buolamwini JK
    J Med Chem; 2003 Oct; 46(22):4657-68. PubMed ID: 14561085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological evaluation of 4-anilinoquinolines as potent inhibitors of epidermal growth factor receptor.
    Pawar VG; Sos ML; Rode HB; Rabiller M; Heynck S; van Otterlo WA; Thomas RK; Rauh D
    J Med Chem; 2010 Apr; 53(7):2892-901. PubMed ID: 20222733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tyrphostins. 5. Potent inhibitors of platelet-derived growth factor receptor tyrosine kinase: structure-activity relationships in quinoxalines, quinolines, and indole tyrphostins.
    Gazit A; App H; McMahon G; Chen J; Levitzki A; Bohmer FD
    J Med Chem; 1996 May; 39(11):2170-7. PubMed ID: 8667360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 7-Alkoxy-4-phenylamino-3-quinolinecar-bonitriles as dual inhibitors of Src and Abl kinases.
    Boschelli DH; Wang YD; Johnson S; Wu B; Ye F; Barrios Sosa AC; Golas JM; Boschelli F
    J Med Chem; 2004 Mar; 47(7):1599-601. PubMed ID: 15027848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tyrphostins. 6. Dimeric benzylidenemalononitrile tyrophostins: potent inhibitors of EGF receptor tyrosine kinase in vitro.
    Gazit A; Osherov N; Gilon C; Levitzki A
    J Med Chem; 1996 Dec; 39(25):4905-11. PubMed ID: 8960549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.